Skip to content

Study on the detection of drug concentration of first-line anti tuberculosis drugs in children using dry blood spot paper method

Study on the detection of drug concentration of first-line anti tuberculosis drugs in children using dry blood spot paper method - Children's HRZE dry blood spot method

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099263
Enrollment
Unknown
Registered
2025-03-20
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis in children

Interventions

Group 1 (Child age 3 years old, 7 years old, 14 years old,<18 years old):None

Sponsors

National Clinical Key Specialty Construction project
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1 Conform to the diagnostic criteria for tuberculosis in children; 2 Use isoniazid, rifampicin, pyrazinamide, and ethambutol to treat tuberculosis in children; 3 Oral administration; 4 Under 18 years old; 5 No other serious underlying diseases

Exclusion criteria

Exclusion criteria: 1 Intravenous administration; 2 Known allergies to isoniazid, rifampicin, pyrazinamide, ethambutol, or their excipients; 3 Patients with liver dysfunction or liver disease (referring to those before medication) and severe gastrointestinal reactions; 4 Patients with poor medication adherence

Design outcomes

Primary

MeasureTime frame
plasma durg concentration;

Countries

China

Contacts

Public ContactYu Zhu

West China Second Hospital of Sichuan University

zhuyu_wj@163.com+86 181 8060 9101

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026